ISLAMABAD: Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal will inaugurate the Pak Pharma & Healthcare Expo 2026 as Chief Guest on August 12 at 11:00 AM at Tulip Marquee, Murree Road, Islamabad.
The two-day international exhibition and conference, being organised by Prime Event Management, will continue from August 12 to 13, 2026, bringing together pharmaceutical and healthcare industry leaders, manufacturers, professionals, business representatives, regulators and other key stakeholders from Pakistan and abroad.
Kamran Abbasi, Director of Prime Event Management and organiser of the Pak Pharma & Healthcare Expo, said the exhibition aims to connect key stakeholders of Pakistan’s pharmaceutical and healthcare sectors on a common platform. He said the Expo will provide opportunities for interaction between manufacturers, suppliers, healthcare professionals, industry associations, regulators and decision-makers while promoting new technologies, business linkages, investment and collaboration in the sector.
The Expo will showcase pharmaceutical processing and packaging machinery, laboratory and testing equipment, raw materials and active pharmaceutical ingredients, medical diagnostic equipment, hospital equipment and consumables, medicines and healthcare products, and surgical instruments.
The event is supported by the Pakistan Pharmaceutical Manufacturers’ Association (PPMA), Rawalpindi Chamber of Commerce & Industry (RCCI), Sarhad Chamber of Commerce & Industry (SCCI), Pakistan Pharmacists Association (PPA), and Nutraceutical Manufacturers Association of Pakistan (NMAP).
In a significant regulatory engagement alongside the Expo, the Drug Regulatory Authority of Pakistan (DRAP) has announced dedicated interaction sessions with the pharmaceutical and healthcare industry. According to an official communication issued by the CEO Secretariat of DRAP, the sessions are aimed at promoting regulatory awareness, transparency and meaningful engagement with industry stakeholders.
DRAP said the sessions will provide an opportunity to share key regulatory requirements and expectations while enabling industry representatives to seek clarification and raise matters of common interest through structured discussions followed by question-and-answer sessions.
The regulatory interaction will cover key areas including pharmacovigilance obligations of pharmaceutical manufacturers under the Pharmacovigilance Rules; registration applications, common deficiencies and regulatory expectations; and Alternative Medicines & Health Products Rules, 2026, with a focus on the regulatory framework and industry readiness.
DRAP has also requested major pharmaceutical, nutraceutical and healthcare industry associations to encourage their member companies and relevant representatives to participate in the sessions and submit questions and issues of broader industry relevance for discussion. The Authority said sustained and constructive engagement with industry is important for promoting regulatory clarity, improved compliance and effective implementation of regulatory requirements.
Prominent regulatory, industry and business leaders participating as special guests include Dr. Obaidullah, Chief Executive Officer, Drug Regulatory Authority of Pakistan (DRAP); Usman Shaukat, Managing Director of Bio-Labs (Pvt.) Ltd., Chairman PPMA North and President Rawalpindi Chamber of Commerce & Industry; Muhammad Danish Khan, CEO of Herbiotics Health Care and Founder & Chairman of the Nutraceutical Manufacturers Association of Pakistan; Muhammad Alamgir Rao, President Pakistan Pharmacists Association and Deputy Secretary, Health & Population Department, Government of Punjab; and Junaid Altaf, President Sarhad Chamber of Commerce & Industry.
The Expo is expected to provide a platform for pharmaceutical and healthcare stakeholders to explore new technologies, strengthen professional and business linkages, exchange knowledge and identify opportunities for collaboration and investment.
Local and foreign exhibitors are expected to participate in the two-day exhibition, which will highlight new developments, regulatory priorities and emerging business and investment opportunities across Pakistan’s pharmaceutical and healthcare industries.
